Deal Announcements

StageMark Nets $1.6 Million In Series B

Tuesday, April 24, 2007 5:00:00 AM PDT | VentureDeal Staff

PITTSBURGH, PA -- StageMark, Inc. said it raised $1.6 million in a second round of institutional venture funding from numerous investors.

StageMark is developing diagnostic and research products and services in the areas of autoimmune and inflammatory conditions, initially focusing on lupus.  The company's technology is a result of research at the University of Pittsburgh Medical Center.

Investors in the round included BioAdvance Ventures via Quaker BioVentures, University City Science Center, BlueTree Capital Partners, Innovation Works, Meyer Ventures and the Pittsburgh Life Sciences Greenhouse.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1